Mail-in sputum tests could simplify infection monitoring for cystic fibrosis patients

NCT ID NCT06950892

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether adults with cystic fibrosis can collect sputum samples at home and mail them in for infection testing, compared to standard clinic collection. With 150 participants, researchers will compare how well home samples detect bacteria like Pseudomonas aeruginosa versus clinic samples. The goal is to see if remote collection is a reliable option for monitoring lung infections.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could show that home-collected sputum samples are reliable for detecting lung infections, making monitoring easier and more convenient for people with cystic fibrosis.
What could go wrong
This is an observational study, not testing a new treatment. It may find that home samples are less accurate than clinic samples, limiting their use in routine care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Johns Hopkins University

    RECRUITING

    Baltimore, Maryland, 21287, United States

  • National Jewish Health

    RECRUITING

    Denver, Colorado, 80206, United States

  • University of Pennsylvania

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.